Answers are grounded in this paper and cite their sources.
Zika virus (ZIKV) is a flavivirus transmitted by Aedes mosquitoes. Most infected individuals present mild symptoms; however, vertical transmission of ZIKV can lead to Congenital Zika Syndrome (CZS), which includes microcephaly, neurological, hearing, ophthalmological, and morphological abnormalities. Given the high prevalence of dengue virus (DENV) exposure and antibody cross-reactivity among flaviviruses, understanding how maternal humoral antibody profiles relate to neonatal outcomes after ZIKV infection is important. In this exploratory study, we evaluated maternal and neonatal anti-ZIKV total IgG, anti-ZIKV IgG1 and anti-ZIKV IgG3, and anti-DENV IgG reactivity in relation to maternal-neonatal antibody patterns and neonatal outcomes. Samples from pregnant women and their newborns were collected in Brazil, including pregnancies with microcephaly and other clinical or imaging abnormalities. Anti-ZIKV and anti-DENV IgG reactivity was measured by ELISA. Lower neonatal anti-ZIKV IgG3 reactivity was observed in pregnancies with ophthalmological abnormalities in the individual comparison, although this association did not remain significant after false discovery rate adjustment. Lower neonatal anti-DENV IgG reactivity was observed in pregnancies with ophthalmological abnormalities and with any clinical or imaging abnormality, and both associations remained significant after false discovery rate adjustment. These exploratory associations are hypothesis-generating and do not establish functional protection or a causal role for the measured antibody profiles.
No takes yet. Share an insight, caveat, or question.
Antonelli et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: